What are the effects and benefits of Rivaroxaban tablets?

Nov 11, 2024 Source: Cainiu Health
Dr. Tian Hongbo
Introduction
In general, the effects and benefits of rivaroxaban tablets include prevention of venous thrombosis, treatment of deep vein thrombosis, reduction of pulmonary embolism risk, stroke prevention in patients with non-valvular atrial fibrillation, and treatment of acute coronary syndromes. To avoid unnecessary harm to the body, it is recommended to use or discontinue the medication under the guidance of a qualified physician. Regular follow-up examinations are important, and medication regimens should be adjusted according to medical advice.

Under normal circumstances, the effects and benefits of rivaroxaban tablets include prevention of venous thrombosis, treatment of deep vein thrombosis (DVT), reduction of pulmonary embolism risk, stroke prevention in patients with non-valvular atrial fibrillation, and treatment of acute coronary syndrome. Specific analyses are as follows:

1. Prevention of venous thrombosis: Rivaroxaban tablets can be used to prevent postoperative venous thromboembolism in adult patients undergoing elective hip or knee replacement surgery.

2. Treatment of deep vein thrombosis: Rivaroxaban effectively reduces thrombus volume, prevents thrombus extension, and lowers the risks of recurrence and pulmonary embolism within six months after treatment.

3. Reduction of pulmonary embolism risk: Rivaroxaban is suitable for adult patients with non-valvular atrial fibrillation who have conditions such as congestive heart failure or hypertension, helping to reduce the risk of pulmonary embolism.

4. Stroke prevention in patients with non-valvular atrial fibrillation: Rivaroxaban inhibits the conversion of prothrombin to thrombin, thereby preventing the formation of fibrin clots. This effectively blocks intracardiac thrombus formation and subsequently reduces the risk of stroke caused by thromboembolism.

5. Treatment of acute coronary syndrome: When used in combination with antiplatelet agents, rivaroxaban suppresses coagulation factors, further reducing the formation and extension of intracoronary thrombi, improving myocardial blood supply, and lowering the risk of recurrent cardiovascular events.

To avoid unnecessary harm to the body, it is recommended that medication be used or discontinued only under the guidance of a qualified physician. During treatment, regular follow-up evaluations should be conducted, and medication regimens should be adjusted according to medical advice. Additionally, maintaining healthy lifestyle habits and avoiding strenuous exercise or high-risk activities is important to minimize the risk of bleeding.